Goldberg Andrew D. - Insider Non-Derivative Transactions at Tarsus Pharmaceuticals, Inc. (TARS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 24, 2024, Goldberg Andrew D.'s relationship to Tarsus Pharmaceuticals, Inc. (TARS) is Director, and currently has 6,350 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TARS insiders.
Data Source: SEC.
Goldberg Andrew D. - Insider Non-Derivative Transactions of TARS Common Stock
Goldberg Andrew D. - Insider Non-Derivative Transactions at TARS
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jun 25, 2024 | M -- (Common Stock) | 3350 | 0 | 6350 |
Dec 16, 2023 | P -- (Common Stock) | 1000 | 18.96 | 3000 |
Jun 17, 2023 | M -- (Common Stock) | 2000 | 0 | 2000 |